Literature DB >> 19020060

Single-nucleotide polymorphisms in Rv2629 are specific for Mycobacterium tuberculosis genotypes Beijing and Ghana but not associated with rifampin resistance.

Susanne Homolka1, Claudio Köser, John Archer, Sabine Rüsch-Gerdes, Stefan Niemann.   

Abstract

Sequence analysis of 58 multidrug-resistant Mycobacterium tuberculosis complex strains from Germany and 55 susceptible strains from a reference collection comprising major phylogenetic lineages confirmed that variations in Rv2629, 191A/C and 965C/T, are specific for genotypes Beijing and Ghana, respectively, but not involved in the development of rifampin (rifampicin) resistance.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19020060      PMCID： PMC2620844          DOI： 10.1128/JCM.01237-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates.

Authors:  Caroline Allix-Béguec; Dag Harmsen; Thomas Weniger; Philip Supply; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2008-06-11       Impact factor: 5.948

2.  Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.

Authors:  Doris Hillemann; Michael Weizenegger; Tanja Kubica; Elvira Richter; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.

Authors:  M Heep; B Brandstätter; U Rieger; N Lehn; E Richter; S Rüsch-Gerdes; S Niemann
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions.

Authors:  Joakim Starck; Gunilla Källenius; Britt-Inger Marklund; Dan I Andersson; Thomas Akerlund
Journal:  Microbiology       Date:  2004-11       Impact factor: 2.777

5.  The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated.

Authors:  Michael B Reed; Sebastien Gagneux; Kathryn Deriemer; Peter M Small; Clifton E Barry
Journal:  J Bacteriol       Date:  2007-01-19       Impact factor: 3.490

Review 6.  Laboratory diagnostic aspects of drug resistant tuberculosis.

Authors:  Linda M Parsons; Akos Somoskövi; Richard Urbanczik; Max Salfinger
Journal:  Front Biosci       Date:  2004-09-01

7.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.

Authors:  Michael B Reed; Pilar Domenech; Claudia Manca; Hua Su; Amy K Barczak; Barry N Kreiswirth; Gilla Kaplan; Clifton E Barry
Journal:  Nature       Date:  2004-09-02       Impact factor: 49.962

8.  A newly identified 191A/C mutation in the Rv2629 gene that was significantly associated with rifampin resistance in Mycobacterium tuberculosis.

Authors:  Qingzhong Wang; Jun Yue; Lu Zhang; Ying Xu; Jiazhen Chen; Min Zhang; Bingdong Zhu; Hongyan Wang; Honghai Wang
Journal:  J Proteome Res       Date:  2007-10-31       Impact factor: 4.466

9.  Rifampin resistance, Beijing-W clade-single nucleotide polymorphism cluster group 2 phylogeny, and the Rv2629 191-C allele in Mycobacterium tuberculosis strains.

Authors:  Soumitesh Chakravorty; Bola Aladegbami; Alifiya S Motiwala; Yang Dai; Hassan Safi; Michael Brimacombe; Danica Helb; David Alland
Journal:  J Clin Microbiol       Date:  2008-06-11       Impact factor: 5.948

10.  Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review.

Authors:  Judith R Glynn; Jennifer Whiteley; Pablo J Bifani; Kristin Kremer; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883
View more
  9 in total

1.  Ultrafast Assessment of the Presence of a High-Risk Mycobacterium tuberculosis Strain in a Population.

Authors:  Laura Pérez-Lago; Marta Herranz; Iñaki Comas; María Jesús Ruiz-Serrano; Paula López Roa; Emilio Bouza; Darío García-de-Viedma
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

2.  Polymorphisms in isoniazid and prothionamide resistance genes of the Mycobacterium tuberculosis complex.

Authors:  Michaela Projahn; Claudio U Köser; Susanne Homolka; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 3.  Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.

Authors:  Claudio U Köser; Silke Feuerriegel; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

4.  Streptomycin resistance and lineage-specific polymorphisms in Mycobacterium tuberculosis gidB gene.

Authors:  Fernanda S Spies; Andrezza W Ribeiro; Daniela F Ramos; Marta O Ribeiro; Anandi Martin; Juan Carlos Palomino; Maria Lucia R Rossetti; Pedro Eduardo A da Silva; Arnaldo Zaha
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

5.  Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.

Authors:  Silke Feuerriegel; Claudio Köser; Leona Trübe; John Archer; Sabine Rüsch Gerdes; Elvira Richter; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

6.  Rv2629 Overexpression Delays Mycobacterium smegmatis and Mycobacteria tuberculosis Entry into Log-Phase and Increases Pathogenicity of Mycobacterium smegmatis in Mice.

Authors:  Dan Liu; Kewei Hao; Wenjie Wang; Chao Peng; Yue Dai; Ruiliang Jin; Wenxi Xu; Lei He; Hongyan Wang; Honghai Wang; Lu Zhang; Qingzhong Wang
Journal:  Front Microbiol       Date:  2017-11-15       Impact factor: 5.640

7.  First molecular epidemiology study of Mycobacterium tuberculosis in Kiribati.

Authors:  Eman Aleksic; Matthias Merker; Helen Cox; Bereka Reiher; Zamberi Sekawi; Anna C Hearps; Claire E Ryan; Adele V Lee; Regis Goursaud; Clement Malau; Janet O'Connor; Catherine L Cherry; Stefan Niemann; Suzanne M Crowe
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

Review 8.  Prevalence and occurrence rate of Mycobacterium tuberculosis Haarlem family multi-drug resistant in the worldwide population: A systematic review and meta-analysis.

Authors:  Rashid Ramazanzadeh; Daem Roshani; Pegah Shakib; Samaneh Rouhi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

9.  Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland.

Authors:  Tomasz Jagielski; Helena Ignatowska; Zofia Bakuła; Łukasz Dziewit; Agnieszka Napiórkowska; Ewa Augustynowicz-Kopeć; Zofia Zwolska; Jacek Bielecki
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.